feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Wrong Pills Shipped: BP Med Recall!

Wrong Pills Shipped: BP Med Recall!

10 Feb

•

Summary

  • Blood pressure medication recalled due to possible wrong drug in bottles.
  • Patients can identify incorrect pills by their distinct shape and markings.
  • Swapping medication can cause dangerous side effects and blood pressure spikes.

A recall has been issued for two specific lots of MAR-Amlodipine 5 milligram tablets, a medication prescribed for high blood pressure and chest pain. The recall, initiated by Marcan Pharmaceuticals Inc. and announced by Health Canada, stems from a packaging error. It is possible that some bottles contain midodrine 2.5 milligram tablets, which are intended for the treatment of low blood pressure.

Patients who have received the recalled medication are advised to visually inspect their tablets. The correct MAR-Amlodipine 5mg tablets are white or off-white, flat, eight-sided, and marked with '210' and '5'. Conversely, the mislabeled midodrine 2.5mg tablets are white, round, and imprinted with 'M2' on one side. Health Canada urges anyone with the round tablets to return their medication to the pharmacy for a replacement.

The consequences of inadvertently taking midodrine instead of amlodipine can be severe. Health Canada warns that such a substitution could result in a dangerous elevation of blood pressure, leading to symptoms like dizziness, fainting, and potential organ damage. Individuals experiencing dizziness, unusually high blood pressure, or slow heart rates should contact a healthcare professional immediately. Furthermore, anyone exhibiting symptoms of chest pain, sudden severe headache, speech impairment, or sudden weakness should seek emergency medical attention.

trending

India US trade tariffs slashed

trending

Salesforce lays off 1000

trending

Dhakshineswar Suresh Davis Cup hero

trending

CBSE board exams: key details

trending

US lowers Bangladesh tariffs

trending

iPhone 17 Croma Valentine's sale

trending

Herb may reverse hair loss

trending

Netherlands face prepared Namibia

trending

Jana Nayagan movie court case

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Two lots of MAR-Amlodipine 5 milligram tablets have been recalled due to a potential mix-up with another drug.
Patients should look at the tablets; the correct 5mg MAR-Amlodipine tablets are white, flat, eight-sided, marked '210' and '5', while the incorrect round midodrine 2.5mg tablets are marked 'M2'.
Substituting amlodipine with midodrine can lead to serious side effects such as a dangerous increase in blood pressure, dizziness, fainting, and organ damage.

Read more news on

Healthside-arrow

You may also like

Lethal 'Louis Vuitton' Drug Sparks Overdose Crisis

31 Jan • 78 reads

Regeneron's Drug: Weight Loss Plus Heart Health?

31 Jan • 81 reads

article image

AstraZeneca India Gets Green Light for New Cancer Treatment

31 Jan • 66 reads

article image

Weight-Loss Jabs Linked to Severe Pancreatitis Risk

30 Jan • 100 reads

article image

First Ever Treatment for Menkes Disease Approved

13 Jan • 202 reads

article image